Camp4 Therapeutics Corp (CAMP)

$1.51 -0.01 (-0.66%)
Market Cap 33.67M
Revenue (ttm) 650,000.00
Net Income (ttm) -51.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,967.69%
Debt to Equity Ratio 0.00
Volume 12,295
Avg Vol 125,862
Day's Range N/A - N/A
Shares Out 20.16M
Stochastic %K 30%
Beta N/A
Analysts Strong Sell
Price Target $15.25

Company Profile

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeuti...

Industry: Biotechnology
Sector: Healthcare
Phone: 617-651-8867
Address:
One Kendall Square, 3rd Floor Building 1400 West, Cambridge, United States
Superthi
Superthi Aug. 5 at 10:05 AM
$MLGO come over to $CAMP we are taking off🚀🚀🚀
0 · Reply
Superthi
Superthi Aug. 5 at 10:01 AM
$GME come over to $CAMP we are taking off🚀🚀🚀
1 · Reply
Superthi
Superthi Aug. 5 at 9:54 AM
$CAMP we are taking off🚀🚀🚀
0 · Reply
Bigsaltyone
Bigsaltyone Jul. 25 at 9:37 AM
$CAMP
0 · Reply
Fib7867
Fib7867 Jul. 24 at 6:56 AM
#myCAMPanalysis $CAMP
2 · Reply
hggfddgfgf
hggfddgfgf Jul. 19 at 2:30 PM
$CAMP high ps
0 · Reply
PurpleSquirrel2020
PurpleSquirrel2020 Jul. 14 at 6:04 PM
$CAMP $11 IPO now at $1.50 JPMorgan deal that is insider held by almost 87% of shares. Float is 2.64 mil. Nobody is looking at this one … yet
0 · Reply
Fib7867
Fib7867 Jul. 10 at 8:19 PM
#myCAMPanalysis $CAMP
0 · Reply
RCInvestor
RCInvestor Jul. 1 at 8:29 PM
$YAAS $GVH $CAMP overnight
0 · Reply
ihuntbiggame
ihuntbiggame Jul. 1 at 6:13 PM
$WOLF $ARBK $PWM $CAMP
0 · Reply
Latest News on CAMP
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

May 16, 2025, 6:00 AM EDT - 2 months ago

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights

May 13, 2025, 4:05 PM EDT - 3 months ago

CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

Apr 28, 2025, 4:30 PM EDT - 3 months ago

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2

Apr 10, 2025, 6:56 AM EDT - 4 months ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2

EWTX GNFT

CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 27, 2025, 4:05 PM EDT - 4 months ago

CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update

CAMP4 Appoints Multiple Industry Veterans to its Board of Directors

Mar 18, 2025, 8:00 AM EDT - 5 months ago

CAMP4 Appoints Multiple Industry Veterans to its Board of Directors

CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Mar 13, 2025, 10:39 PM EDT - 5 months ago

CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Mar 13, 2025, 2:58 PM EDT - 5 months ago

CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

CAMP4 to Participate in Upcoming Investor Conferences

Feb 6, 2025, 8:00 AM EST - 6 months ago

CAMP4 to Participate in Upcoming Investor Conferences

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

Jan 7, 2025, 4:05 PM EST - 7 months ago

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

Dec 2, 2024, 8:00 AM EST - 8 months ago

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

CAMP4 Reports Third Quarter 2024 Financial Results

Nov 21, 2024, 4:05 PM EST - 9 months ago

CAMP4 Reports Third Quarter 2024 Financial Results

CAMP4 Analyst Highlights Rare Disease Platform Potential

Nov 5, 2024, 3:06 PM EST - 9 months ago

CAMP4 Analyst Highlights Rare Disease Platform Potential

CAMP4 Announces Pricing of Initial Public Offering

Oct 10, 2024, 7:07 PM EDT - 10 months ago

CAMP4 Announces Pricing of Initial Public Offering

Camp4 Therapeutics Targets IPO On Early Positive Results

Oct 1, 2024, 4:30 PM EDT - 11 months ago

Camp4 Therapeutics Targets IPO On Early Positive Results

Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO

Sep 20, 2024, 3:35 PM EDT - 11 months ago

Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO

Kaiser Permanente-backed biopharma CAMP4 files for US IPO

Sep 20, 2024, 2:23 PM EDT - 11 months ago

Kaiser Permanente-backed biopharma CAMP4 files for US IPO

CAMP4 Therapeutics IPO Registration Document (S-1)

Sep 20, 2024, 1:35 PM EDT - 11 months ago

CAMP4 Therapeutics IPO Registration Document (S-1)

CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders

Sep 17, 2024, 8:00 AM EDT - 11 months ago

CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders

Superthi
Superthi Aug. 5 at 10:05 AM
$MLGO come over to $CAMP we are taking off🚀🚀🚀
0 · Reply
Superthi
Superthi Aug. 5 at 10:01 AM
$GME come over to $CAMP we are taking off🚀🚀🚀
1 · Reply
Superthi
Superthi Aug. 5 at 9:54 AM
$CAMP we are taking off🚀🚀🚀
0 · Reply
Bigsaltyone
Bigsaltyone Jul. 25 at 9:37 AM
$CAMP
0 · Reply
Fib7867
Fib7867 Jul. 24 at 6:56 AM
#myCAMPanalysis $CAMP
2 · Reply
hggfddgfgf
hggfddgfgf Jul. 19 at 2:30 PM
$CAMP high ps
0 · Reply
PurpleSquirrel2020
PurpleSquirrel2020 Jul. 14 at 6:04 PM
$CAMP $11 IPO now at $1.50 JPMorgan deal that is insider held by almost 87% of shares. Float is 2.64 mil. Nobody is looking at this one … yet
0 · Reply
Fib7867
Fib7867 Jul. 10 at 8:19 PM
#myCAMPanalysis $CAMP
0 · Reply
RCInvestor
RCInvestor Jul. 1 at 8:29 PM
$YAAS $GVH $CAMP overnight
0 · Reply
ihuntbiggame
ihuntbiggame Jul. 1 at 6:13 PM
$WOLF $ARBK $PWM $CAMP
0 · Reply
RCInvestor
RCInvestor Jul. 1 at 6:13 PM
$WOLF $ARBK still in vwap. Wolf seems more bullish $PWM under vwap - $CAMP will be next
1 · Reply
RCInvestor
RCInvestor Jul. 1 at 4:47 PM
$CAMP harmonic pattern.. I like it here took a starter. As always manage your risk
0 · Reply
builderup
builderup Jun. 27 at 11:49 AM
$SKYE not a bad 4 day run. $CAMP $INTS
0 · Reply
Fib7867
Fib7867 Jun. 26 at 7:55 PM
$CAMP #myCAMPanalysis
0 · Reply
StockScanners
StockScanners Jun. 25 at 4:28 AM
$CAMP Reached 1.81, keep watch
0 · Reply
builderup
builderup Jun. 24 at 7:45 PM
Nice 2 day run. Let’s keep it going! Scaling out but still strong. Patience $CAMP $SKYE $INTS
0 · Reply
StockScanners
StockScanners Jun. 23 at 11:00 PM
$CAMP keep watch if this holds above 1.60
1 · Reply
builderup
builderup Jun. 23 at 9:44 AM
Weekly watch list… $CAMP $SKYE $INTS Weekly watchlist
1 · Reply
PenkeTrading
PenkeTrading Jun. 17 at 6:29 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of CAMP4 THERAPEUTICS CORPORATION. Is that bullish or bearish? $CAMP #RsiOversold #NASDAQ
0 · Reply
jacobm50
jacobm50 May. 30 at 5:33 PM
$CAMP yes.. I can feel the momentum 😴😴😴
0 · Reply
BioTechHealthX
BioTechHealthX May. 30 at 3:20 PM
$CAMP Following its $75M IPO, CAMP4 is gaining momentum in the biotech world with breakthrough therapies for rare and neurodegenerative diseases. https://biotechhealthx.com/biotech-news/camp4-therapeutics-camp-is-game-changer-in-rna-driven-drug-discovery/
0 · Reply
jacobm50
jacobm50 May. 27 at 7:23 PM
$CAMP I’m in at 2. Let’s ride
1 · Reply